A new report from the American Society of Health System Pharmacists (ASHP) revealed that prescription drug spending in the United States reached nearly $806 billion in 2024, up 10.2% from 2023. The increase was largely driven by the demand for weight loss medications, including glucagon like peptide-1 (GLP-1) drugs. GLP-1 medications are prescribed for diabetes and obesity and are now the top drug category by total spending and the fastest-growing segment on the market.
